Rivian’s delivery trajectory weakened in 2025, with total vehicle shipments falling to 53,230 units, down from 54,830 in 2024 and 56,420 in 2023. In Q3, the company delivered 13,201 vehicles, its strongest quarter since the 15,564 units delivered in Q3 2023, but deliveries slipped to 9,745 in Q4. Management attributes the year-end drop to production constraints and inventory balancing, underscoring the challenge of scaling the existing R1 platform ahead of the R2 launch scheduled for the first half of 2026. With the R2 launch edition priced near $60,000 and a later base model targeting roughly $45,000, Rivian forecasts significant volume growth but acknowledges that initial ramp-up will tax its manufacturing capacity and could delay breakeven on unit economics.

In the third quarter of 2025, Rivian reported revenue of $1.56 billion, a 78% increase year over year, driven primarily by higher R1 deliveries and improved average selling prices. Gross profit turned positive at $24 million, up by $416 million from a steep gross loss a year earlier, marking the company’s first positive gross margin on a consolidated basis. However, automotive gross profit remained negative $130 million, reflecting continued high cost of goods sold relative to vehicle revenue. Net losses narrowed but still exceeded $500 million for the quarter, and operating expenses remained elevated at $800 million, driven by increased R&D spend on the R2 platform and pre-launch marketing activities.

Investor sentiment has been volatile this week following two major analyst downgrades. Wolfe Research lowered its rating to underperform, pointing to extended EBITDA losses and softer-than-expected EV demand, while UBS cut its view to sell, citing execution risks around the R2 rollout. Both firms noted that the accelerating competition from Chinese EV makers could erode Rivian’s pricing power. In contrast, Piper Sandler raised its outlook, arguing that the R2 platform’s lower price point could unlock volume potential and drive improved scale economics by late 2027. The mixed analyst views highlight the key risks investors face: execution on the R2 ramp, near-term margin pressure from a more affordable product mix, and intensifying global competition.